IRWD tops Q2 earnings estimates, misses on revenues and lifts its 2026 outlook as strong Linzess dem

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2026 Earnings Call Transcript

Ironwood Pharmaceuticals NASDAQ: IRWD reported second-quarter results marked by higher LINZESS sales

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.31 per share, beating the Zac

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and c

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

Despite the recent market selloff, earnings expectations continue to rise: The S&P 500's Q2 EPS is p

Ironwood Pharmaceuticals trades at a 40% discount to its risk-adjusted sum-of-the-parts valuation, a

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

– Ironwood Chief Medical Officer and Head of Research and Drug Development Dr. Michael Shetzline to

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech

Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's

Indivior, Aurinia, Ironwood, Altimmune and Marker have been highlighted in this Industry Outlook art

Innovation is at its peak in the Zacks Medical-Drugs industry. INDV, AUPH, IRWD, ALT and MRKR may pr

Ironwood sees Linzess momentum as strong demand, a pediatric expansion and pricing changes are expec

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced that managem

Ironwood gains FDA approval to expand Linzess use to children aged two to five years with functional

[url="]Ironwood Pharmaceuticals, Inc.[/url] (Nasdaq: IRWD), a biotechnology company developing and c

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company deve

Ironwood Pharmaceuticals presents a contrarian buy opportunity after a 14.5% decline driven by CFO r

Ironwood Pharmaceuticals is downgraded to Hold after the CFO's resignation and despite record Q1 202

Dow Jones up 200 points, Avanos Medical Inc rose on going-private deal. Big gainers include AVNS, TV

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

  Friday's session saw 225 companies set new 52-week lows.

  On Wednesday, 179 companies reached new 52-week lows.

  Wednesday's session saw 150 companies set new 52-week lows.

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fisc

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

  During Monday's trading, 528 companies set new 52-week lows.

  On Friday, 404 stocks made new 52-week lows.

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

  Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report